This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|February 16, 2011
Your chance to be published in PTE!
Author(s)Stephanie Sutton
Want to take part in Pharm. Tech. Europe's roundtable on tabletting and stand a chance of seeing your opinion published in a magazine that reaches 18,000 professionals across Europe?
Advertisement
Want to take part in Pharm Tech Europe's feature on packaging and stand a chance at seeing your opinion published in a magazine that reaches 18,000 professionals across Europe?
We will be publishing a special feature on issues and innovations in packaging in the May print issue of Pharmaceutical Technology Europe and we would like to hear your opinions, grievances or wish lists!
Advertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
France Remains One of Europe’s Leading Biotech Funding Hubs
2
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
3
Choosing a Connected Product Technology for Anticounterfeiting
4
Investing in Protecting Pharma Products
5